Table 1:
Patient demographics and tumor characteristics
| No. | Age, Sex | Histology |
IVIM Parameters |
ADC (× 10−3 mm2/s) | |||||
|---|---|---|---|---|---|---|---|---|---|
| Pathologic Diagnosis | WHO Grade | MIB-1 (%) | MVD | D (× 10−3 mm2/s) | f (%) | D* (× 10−3 mm2/s) | |||
| 1 | 6 yr, M | Diffuse midline glioma, H3 K27M-mutant | IV | 59.2 | 3.1 | 1.50 | 16.4 | 5.6 | 1.61 |
| 2 | 4 yr, M | Medulloblastoma, classic, histologically defined | IV | 15.6 | 34.7 | 0.30 | 37.7 | 13.7 | 0.56 |
| 3 | 11 yr, M | Medulloblastoma, classic, histologically defined | IV | 72.6 | 10.2 | 0.53 | 27.1 | 30.2 | 0.87 |
| 4 | 3 yr, M | Atypical teratoid/rhabdoid tumor | IV | 50.0 | 11.0 | 0.86 | 14.1 | 9.0 | 0.98 |
| 5 | 2 yr, F | Anaplastic ependymoma | III | 23.2 | 12.5 | 0.87 | 19.3 | 18.4 | 1.02 |
| 6 | 3 yr, M | Anaplastic ependymoma | III | 19.6 | 4.3 | 1.15 | 16.8 | 5.5 | 1.30 |
| 7 | 6 yr, F | Anaplastic ependymoma | III | 58.4 | 10.1 | 0.71 | 20.7 | 41.7 | 0.96 |
| 8 | 12 yr, M | Diffuse astrocytoma, IDH wild-type | II | 2.1 | 2.1 | 1.22 | 8.4 | 33.3 | 1.29 |
| 9 | 1 yr, M | Pilocytic astrocytoma | I | 4.4 | 5.8 | 1.45 | 3.5 | 5.5 | 1.50 |
| 10 | 3 yr, F | Pilocytic astrocytoma | I | 6.7 | 4.0 | 1.82 | 7.2 | 10.2 | 1.88 |
| 11 | 3 yr, M | Pilocytic astrocytoma | I | 8.0 | 4.7 | 1.52 | 10.0 | 48.3 | 1.64 |
| 12 | 6 yr, M | Pilocytic astrocytoma | I | 6.0 | 3.2 | 1.72 | 4.2 | 58.4 | 1.78 |
| 13 | 11 yr, F | Pilocytic astrocytoma | I | 4.0 | 5.6 | 1.55 | 5.5 | 12.8 | 1.61 |
| 14 | 2 yr, M | Subependymoma | I | 0.1 | 1.9 | 1.58 | 5.1 | 11.3 | 1.60 |
| 15 | 2 mo, F | Choroid plexus papilloma | I | 0.1 | 13.4 | 1.47 | 17.4 | 11.6 | 1.62 |
| 16 | 10 yr, M | Dysembryoplastic neuroepithelial tumor | I | 2.7 | 1.3 | 1.76 | 10.9 | 4.3 | 1.82 |
| 17 | 15 yr, F | Ganglioglioma | I | 1.0 | 1.1 | 1.21 | 3.6 | 22.4 | 1.24 |
Note:—IDH indicates isocitrate dehydrogenase.